Mangalam Drugs & Organics (BOM:532637) EV-to-EBIT : 87.03 (As of Jun. 05, 2024)

Mangalam Drugs & Organics EV-to-EBIT Chart

Mangalam Drugs & Organics Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-EBIT		Get a 7-Day Free Trial					7.72	4.94	7.12	-	84.22

Mangalam Drugs & Organics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-	-144.02	-27.48	-30.86	-

Competitive Comparison of Mangalam Drugs & Organics's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangalam Drugs & Organics's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's EV-to-EBIT falls into.

Mangalam Drugs & Organics EV-to-EBIT Calculation

Mangalam Drugs & Organics's EV-to-EBIT for today is calculated as:

Mangalam Drugs & Organics's current Enterprise Value is ₹2,475 Mil.
Mangalam Drugs & Organics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangalam Drugs & Organics  (BOM:532637) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mangalam Drugs & Organics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Mangalam Drugs & Organics's Enterprise Value for the quarter that ended in Dec. 2023 was ₹1,554 Mil.
Mangalam Drugs & Organics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangalam Drugs & Organics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics (BOM:532637) Business Description